THERAPEUTIC EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONIST ON COMBAT-INDUCED PROLIFERATIVE VITREORETINOPATHY

Wake Forest University Health Sciences, Winston-Salem NC

Investigators